0.7585
price up icon2.71%   0.02
pre-market  Vorhandelsmarkt:  .78   0.0215   +2.83%
loading

Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.93%
9.04
7.414 7.151 6.385 7.105
Operating Income/Loss
21.93%
-9.04
-7.414 -7.151 -6.385 -7.105
Income/Loss From Continuing Operations Before Tax
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Net Income/Loss
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
129.17
129.17 0.2505 125.77 125.73
Diluted Average Shares
0.00%
129.17
129.17 0.2505 125.77 125.73
Basic Earnings Per Share
40.00%
-0.07
-0.05 -0.05 -0.06 -0.05
Diluted Earnings Per Share
40.00%
-0.07
-0.05 -0.05 -0.06 -0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
Kapitalisierung:     |  Volumen (24h):